International Clinical Psychopharmacology

Journal Title：International Clinical Psychopharmacology

International Clinical Psychopharmacology provides an essential link between research and clinical practice throughout psychopharmacology. It reports on studies in human subjects, both healthy volunteers and patients, which relate the effects of drugs on psychological processes.

A major objective of the journal is to publish fully refereed papers which throw light on the ways in which the study of psychotropic drugs can increase our understanding of psychopharmacology. To this end the journal publishes results of early Phase I and II studies, as well as those of controlled clinical trials of psychotropic drugs in Phase II and IV. Other topics covered include the epidemiology of psychotropic drug prescribing and drug taking, the sociology of psychotropic drugs including compliance, and research into the safety and adverse effects of these compounds.

《国际临床精神药理学》在整个精神药理学领域为研究与临床实践提供了重要联系。它报道了对人类受试者（包括健康志愿者和患者）的研究，这些研究将药物对心理过程的影响联系起来。

该期刊的主要目标是发表经过全面审查的论文，阐明精神药物研究如何增进我们对精神药理学的了解。为此，该期刊发表了早期 I 期和 II 期研究的结果，以及 II 期和 IV 期精神药物对照临床试验的结果。其他主题包括精神药物处方和服药的流行病学、精神药物的社会学（包括依从性）以及对这些化合物的安全性和不良反应的研究。

International Clinical Psychopharmacology创刊于1986年，由Lippincott Williams and Wilkins Ltd.出版商出版，收稿方向涵盖医学 - 精神病学全领域，此刊是中等级别的SCI期刊，所以过审相对来讲不是特别难，但是该刊专业认可度不错，仍然是一本值得选择的SCI期刊 。平均审稿速度 12周，或约稿 ，影响因子指数2.1，该期刊近期没有被列入国际期刊预警名单，广大学者值得一试。